FUT8 and non-small cell lung carcinoma: Moreover, the aberrant upregulation of FUT8 in non-small-cell lung cancer was reported to be correlated with the poor clinical outcomes [93,94], suggesting the involvement of Fut8 in cancer development and its potential as biomarker.